Real-World Safety and Efficacy of Nivolumab in Advanced Squamous and Nonsquamous Non-Small-Cell Lung Cancer: A Retrospective Cohort Study in Croatia, Hungary, and Malta.
Eduard VrdoljakMarko JakopovicLajos GecziKrisztina BogosLidija BoškovićClaude MagriLela BitarŽarko BajićMiroslav SamaržijaPublished in: Journal of oncology (2020)
The safety and efficacy of nivolumab in previously treated patients with advanced NSCLC in the real-world South East Europe clinical settings were consistent with the results of randomized clinical trials and comparable to the results from other countries.